---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-003928"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:33:10.558429+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Vera Therapeutics posts updated corporate presentation on January 8, 2024

## Summary
- Exhibit 99.1 furnished under Item 7.01; no specific financial or operational details disclosed in the filing.
- Presentation available on company website; content not summarized in this filing.
- Forward-looking statements disclaimer included in the presentation.

## SEC filing metadata
- accession: 0001193125-24-003928
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312524003928/0001193125-24-003928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312524003928/d94799d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-003928
- JSON: https://secwatch.observer/filing/0001193125-24-003928.json
- Plain text: https://secwatch.observer/filing/0001193125-24-003928.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.